Advertisement

International Journal of Public Health

, Volume 59, Issue 6, pp 999–1009 | Cite as

Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran

  • Hamid Najafipour
  • Hamid Reza NasriEmail author
  • Mahdi Afshari
  • Mansoor Moazenzadeh
  • Mostafa Shokoohi
  • Afsaneh Foroud
  • Koorosh Etemad
  • Behnam Sadeghi
  • Ali Mirzazadeh
Original Article

Abstract

Objectives

Hypertension (HTN) is an important cause of cardiovascular related morbidity and mortality. This study aimed at providing the prevalence of pre-HTN, diagnosed and undiagnosed HTN, along with its control and associated factors in an adult population.

Methods

5,900 participants aged 15–75 years took part in the study. HTN was verified by examination, self-reported history or using anti-hypertensive drug(s). Pre-hypertension and hypertension were defined as 120–139/80–89 mmHg and >140/>90 mmHg for systolic/diastolic BP, respectively.

Results

The prevalence of hypertension was 18.4 % from which 10.5 %were diagnosed and 7.9 % were undiagnosed. The prevalence of pre-HTN was 35.5 %. HTN increased by age (2.4 % in 15–24 to 49 % in 55–64 years). The men had higher pre-HTN (42.7 vs. 28.1 %) and undiagnosed HTN (11.3 vs. 4.6 %). Of those diagnosed, 56.3 % had uncontrolled BP levels. Smoking, anxiety, obesity, and positive family history of HTN were the most significant predictors for HTN.

Conclusions

Hypertension affected almost one-fifth of the population. Given the poor control in diagnosed hypertensive patients, it is alarming that the current health system in urban areas in Iran is not effective enough to control the epidemic spread of non-communicable diseases.

Keywords

Hypertension Pre-hypertension Undiagnosed hypertension Uncontrolled hypertension Risk factors Iran 

Notes

Acknowledgments

The KERCADR study is funded by the Physiology Research Center at Kerman University of Medical Sciences. We are deeply indebted to our colleagues in the University for helping in recruitment, interviewing and examining the study participants. We profoundly thank the participants of the study. We should send out our best gratitude to Dr. Maliheh Shadkam Farrokhi, who significantly contributed to the project, but unfortunately passed away in the middle of the first round. We also like to thank Nadia Ghazanfari-Moghaddam for proof-reading the manuscript.

Conflict of interest

KE participated in the planning and implementation of non-communicable diseases management in Ministry of Health program. All other authors have no conflicts of interest to be declared.

References

  1. Alves E, Correia S, Barros H, Azevedo A (2012) Prevalence of self-reported cardiovascular risk factors in Portuguese women: a survey after delivery. Int J Public Health 57:837–847PubMedCrossRefGoogle Scholar
  2. Azizi F, Ghanbarian A, Madjid M, Rahmani MJ (2002) Distribution of blood pressure and prevalence of hypertension in Tehran adult population: Tehran lipid and glucose study (TLGS). Hum Hypertens 16:305–312CrossRefGoogle Scholar
  3. Ebrahimi M et al (2010) Social disparities in prevalence, treatment and control of hypertension in Iran: second national surveillance of risk factors of noncommunicable diseases. J Hypertens 28:1620–1629PubMedCrossRefGoogle Scholar
  4. Esteghamati A et al (2008) Prevalence, awareness, treatment, and risk factors associated with hypertension in the iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens 21:620–626PubMedCrossRefGoogle Scholar
  5. Global physical activity questionnaire (GPAQ) analysis guide (2013) Surveillance and population-based prevention, Department of Chronic Diseases and Health Promotion. World Health Organization, Geneva. http://www.who.int/chp/steps/resources/GPAQ_Analysis_Guide.pdf. Accessed 03 September 2013
  6. Gozashti MH, Najmeasadat F, Mohadeseh S, Najafipour H (2013) Determination of most suitable cut off point of waist circumference for diagnosis of metabolic syndrome in Kerman. Diabetes Metab Syndr 6:190–194Google Scholar
  7. Haghdoost AA, Sadeghirad B, Rezazadehkermani M (2008) Epidemiology and heterogeneity of hypertension in Iran: a systematic review. Arch Iran Med 11:444–452PubMedGoogle Scholar
  8. Ibrahim N, Hejazi N, Al-Bar A (2008) Prevalence and determinants of prehypertension and hypertension among preparatory and secondary school teachers in Jeddah. J Egypt Public Health Assoc 83:184–203Google Scholar
  9. Karamatollah R, Shojaie M (2012) The prevalence of pre-hypertension and its association to established cardiovascular risk factors in south of Iran. BMC Res Notes 5:1–6Google Scholar
  10. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22:11–19PubMedCrossRefGoogle Scholar
  11. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223PubMedCrossRefGoogle Scholar
  12. Lawes CMM, Hoorn SV, Rodgers A (2008) Global burden of blood-pressure-related disease. Lancet 371:1513–1518PubMedCrossRefGoogle Scholar
  13. Lim SS, Vos T, Flaxman AD et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2224–2260PubMedCentralPubMedCrossRefGoogle Scholar
  14. Maimaris W, Paty J, Perel P et al (2013) The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med 10:e1001490PubMedCentralPubMedCrossRefGoogle Scholar
  15. Malekzadeh MM et al (2013) Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens 31(7):1364–1371PubMedCentralPubMedCrossRefGoogle Scholar
  16. Mirzazadeh A, Sadeghirad B, Haghdoost AA, Bahreini F, RezazadehKermani M (2009) Theprevalence of obesity in Iran in recent decade; a systematic review and meta-analysis study. Iran J Public Health 38:1–11Google Scholar
  17. Naghibzadeh TA, Khanjani N, Yazdi FV, Varzandeh M, Haghdoost AA (2014) Opium as a risk factor for upper gastrointestinal cancers: a population-based case-control study in Iran. Arch Iran Med 17(1):1–6Google Scholar
  18. Najafipour H et al (2012) Coronary artery disease risk factors in an urban and peri-urban setting, Kerman, southeastern Iran (KERCADR study): methodology and preliminary report. Iran J Public Health 41(9):86–92PubMedCentralPubMedGoogle Scholar
  19. Navadeh S, Sajadi L, Mirzazadeh A, Asgari F, Haghazali M (2011) Housewives’ obesity determinant factors in Iran; national survey—stepwise approach to surveillance. Iran J Public Health 40(2):87–95PubMedCentralPubMedGoogle Scholar
  20. Noohi F, Sarrafzadegan N, Khosravi A, Andalib E (2012) The first Iranian recommendations on prevention, evaluation and management of high blood pressure. ARYA Atheroscler 8:97–118PubMedCentralPubMedGoogle Scholar
  21. Pang W et al (2008) Body mass index and the prevalence of pre-hypertension and hypertension in a Chinese rural population. Intern Med 47(10):893–897PubMedCrossRefGoogle Scholar
  22. Pereira M, Lunet N, Azevedo A, Barros H (2009) Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 27(5):963–975PubMedCrossRefGoogle Scholar
  23. Ploubidis GB et al (2013) Socioeconomic position and later life prevalence of hypertension, diabetes and visual impairment in Nakuru, Kenya. Int J Public Health 58:133–141PubMedCrossRefGoogle Scholar
  24. Rahmanian K, Shojaie M (2012) The prevalence of pre-hypertension and its association to established cardiovascular risk factors in south of Iran. BMC Res Notes 5:386PubMedCentralPubMedCrossRefGoogle Scholar
  25. Ramezani MA, Dastanpour M, Eshaghi SR, Fadaee-Nobari R, Heydari K (2009) Determinants of awareness, treatment and control of hypertension in Isfahan, Central Iran. Arch Med Sci 5:523–530Google Scholar
  26. Robert O. Bonow, Douglas L.Mann, Douglas p Zipes, Peter Libby (2012) Braunwalds heart diseases, 9th edn. Amazon, pp 230–257Google Scholar
  27. Sadeghi M, Roohafza HR, Kelishadi R (2004) Blood pressure and associated cardiovascular risk factors in Iran: Isfahan Healthy Heart Programme. Med J Malaysia 59:460–467PubMedGoogle Scholar
  28. Shadpour K (2000) Primary health care networks in the Islamic Republic of Iran. East Mediterr Health J 6:822–825PubMedGoogle Scholar
  29. Shirani S et al (2009) Awareness, treatment and control of hypertension, dyslipidaemia and diabetes mellitus in an Iranian population: the IHHP study. East Mediterr Health J 15:1455–1463PubMedGoogle Scholar
  30. Sun Z, Zheng L, Wei Y et al (2007) The prevalence of pre-hypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol 30(4):183–187PubMedCrossRefGoogle Scholar
  31. Takian A, Rashidian A, Kabir MJ (2011) Expediency and coincidence in re-engineering a health system: an interpretive approach to formation of family medicine in Iran. Health Policy Plan 26(2):163–173PubMedCrossRefGoogle Scholar
  32. Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N (2013) Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens (Epub ahead of print)Google Scholar
  33. Tsai AC, Liou JC, Chang MC (2007) Interview to study the determinants of hypertension in older adults in Taiwan: a population based cross-sectional survey. Asia Pac J Clin Nutr 16(2):338–345PubMedGoogle Scholar
  34. Whelton PK, He J, Muntner P (2004) Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 18:545–551PubMedCrossRefGoogle Scholar
  35. WHO int BMI classification, Geneva: World health organization (2006) (updated 01/12/2012). http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Accessed 03 September 2013

Copyright information

© Swiss School of Public Health 2014

Authors and Affiliations

  • Hamid Najafipour
    • 1
  • Hamid Reza Nasri
    • 2
    Email author
  • Mahdi Afshari
    • 3
  • Mansoor Moazenzadeh
    • 2
  • Mostafa Shokoohi
    • 1
  • Afsaneh Foroud
    • 2
  • Koorosh Etemad
    • 4
  • Behnam Sadeghi
    • 3
  • Ali Mirzazadeh
    • 1
    • 5
  1. 1.Physiology Research Center, Institute of NeuropharmacologyKerman University of Medical SciencesKermanIran
  2. 2.Physiology Research Center, Institute of Neuropharmacology and Department of Cardiology, Afzalipour Medical Faculty, Shafa HospitalKerman University of Medical SciencesKermanIran
  3. 3.Research Center for Modeling in HealthKerman University of Medical SciencesKermanIran
  4. 4.Center for Non-Communicable Diseases, Deputy of HealthMinistry of Health and Medical EducationTehranIran
  5. 5.Institute for Health Policy StudiesUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations